Rossella De Angelis

Ancona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Rethinking nailfold capillaroscopy in SSc: proposal for a novel binary classification of capillary changes based on severity.

Rethinking nailfold capillaroscopy in SSc: proposal for a novel binary classification of capillary changes based on severity.

Journal: Rheumatology (Oxford, England)

Published: May 26, 2026

The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology.

The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology.

Journal: Journal of translational autoimmunity

Published: April 08, 2026

Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry: Reply.

Comment on: Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry: Reply.

Journal: Rheumatology (Oxford, England)

Published: April 08, 2026

Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab.

Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab.

Journal: Lupus science & medicine

Published: March 27, 2026

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 25, 2026

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.

Journal: Lupus science & medicine

Published: December 18, 2025

Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.

Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.

Journal: Rheumatology (Oxford, England)

Published: November 30, 2025

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

Journal: RMD open

Published: November 02, 2025

Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology.

Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology.

Journal: Journal of autoimmunity

Published: October 12, 2025

Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.

Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry.

Journal: Rheumatology (Oxford, England)

Published: September 16, 2025

Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.

Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.

Journal: Rheumatology (Oxford, England)

Published: September 13, 2025

Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.

Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.

Journal: The Lancet. Rheumatology

Published: July 26, 2025

Showing 1-12 of 74

Last Updated: 09/26/2026